HPV Prevalence % (N°) | Adjusteda OR Vaccinated vs Unvaccinated | ||||
---|---|---|---|---|---|
HPV types | Unvaccinated (n = 537) | Vaccinated (n = 771) | P-value | aOR (95% CI) | P-value |
All types | 17.1 (n 93) | 15.8 (n 124) | 0.39 | 0.89 (0.64-1.24) | 0.495 |
HR types | 13.9 (n 76) | 12.1 (n 94) | 0.21 | 0.79 (0.55-1.13) | 0.203 |
LR types | 6.0 (n 33) | 6.1 (n 51) | 0.96 | 1.00 (0.61-1.63) | 0.989 |
Vaccine types | 5.5 (n 30) | 0.6 (n 5) | <0.001 | 0.10 (0.04-0.27) | <0.001 |
HR vaccine types (16,18) | 5.2 (n 28) | 0.6 (n 5) | <0.001 | 0.11 (0.04-0.30) | <0.001 |
LR vaccine types (6,11) | 0.7 (n 4) | 0.0 (n 0) | 0.02 | NE | - |
Non-vaccine typesb | 14.3 (n 78) | 15.3 (n 120) | 0.88 | 1.08 (0.76-1.52) | 0.681 |
HPV 31 | 2.1 (n 11) | 1.3 (n 11) | 0.58 | 0.89 (0.36-2.20) | 0.795 |
HPV 39 | 0.9 (n 5) | 1.8 (n 17) | 0.22 | 2.05 (0.69-6.05) | 0.196 |
HPV 51 | 1.3 (n 7) | 2.9 (n 21) | 0.08 | 2.40 (0.94-6.13) | 0.067 |
HPV 52 | 2.2 (n 12) | 2.1 (n 15) | 0.60 | 0.75 (0.33-1.70) | 0.495 |
HPV 56 | 0.9 (n 5) | 1.0 (n 9) | 0.94 | 1.17 (0.36-3.82) | 0.790 |
HPV 58 | 0.9 (n 5) | 1.3 (n 11) | 0.58 | 1.16 (0.39-3.46) | 0.791 |
HPV 59 | 0.7 (n 4) | 0.5 (n 6) | 0.77 | 0.89 (0.23-3.48) | 0.870 |
HPV 31, 33, 45 | 2.7 (n 14) | 1.5 (n 13) | 0.30 | 0.95 (0.40-2.27) | 0.908 |
HR-HPV no 16, 18 | 8.6 (n 47) | 8.8 (n 73) | 0.97 | 1.03 (0.68-1.58) | 0.879 |
HR-HPV no 16, 18, 31 | 6.9 (n 38) | 8.3 (n 68) | 0.56 | 1.14 (0.72-1.79) | 0.574 |
HR-HPV no 16, 18, 31, 33, 45 | 6.3 (n 35) | 8.2 (n 67) | 0.35 | 1.24 (0.78-1.97) | 0.356 |
LR non-vaccine types | 4.6 (n 25) | 5.2 (n 43) | 0.66 | 1.17 (0.68-2.02) | 0.576 |